Page 26 - The DHEA Debate - Life Extensions Magazine
P. 26

127. Tissandier O, Peres G, Fiet J, Piette F. Testosterone, dehydroepiandrosterone, insulin-like
               growth factor 1, and insulin in sedentary and physically trained aged men. Eur J Appl Physiol.
               2001 Jul;85(1- 2):177-84.

               128. Bonnefoy M, Patricot MC, Lacour JR, Rahmani A, Berthouze S, Kostka T. Relation
               between physical activity, muscle function and IGF-1, testosterone and DHEAS concentrations
               in the elderly. Rev Med Interne. 2002 Oct;23(10):819-27.
               129. Ando S, Rubens R, Rottiers R. Androgen plasma levels in male diabetics. J Endocrinol
               Invest.1985;7:21-4.
               130. Barrett-Conner E. Lower endogenous androgen levels and dyslipidemia in men with
               noninsulin-dependent diabetes mellitus. Ann Intern Med. 1992;117:807-11.

               131. Thomas N, Morris HA, Scopacasa F, Wishart JM, Need AG. Relationships between age,
               dehydroepiandrosterone sulphate and plasma glucose in healthy men. Age Ageing. 1999
               Mar;28(2):217-20.
               132. Johnson R. Abnormal testosterone: epitestosterone ratios after DHEA supplementation.
               Clin Chemistry. 1999; 45:163-4.
               133. Salek FS, Bigos KL, Kroboth PD. The influence of hormones and pharmaceutical agents
               on DHEA and DHEA-S concentrations: a review of clinical studies. J Clin Pharmacol. 2002
               Mar;42(3):247-66.
               134. Moore TJ, Psaty BM, Furberg CD. Time to act on drug safety. JAMA. 1998 May 20;
               279(19):1571-3.
               135. Kruuse C, Thomsen LL, Birk S, Olesen J. Migraine can be induced by sildenafil without
               changes in middle cerebral artery diameter. Brain. 2003 Jan;126(Pt 1):241-7.
               136. Azarbal B, Mirocha J, Shah PK, Cerek B, Kaul S. Adverse cardiovascular events
               associated with the use of Viagra®. J Am Col Cardiol. 2000; 35 (Suppl A): 553A- 554A.
               137. Meno-Tetang GM, Blum RA, Schwartz KE, Jusko WJ. Effects of oral prasterone
               (dehydroepiandrosterone) on single-dose pharmacokinetics of oral prednisone and cortisol
               suppression in normal women. J Clin Pharmacol. 2001 Nov; 41(11):1195- 205.
               138. Gennari R, Alexander JW. Arginine, glutamine, and dehydroepiandrosterone reverse the
               immunosuppressive effect of prednisone during gut-derived sepsis. Crit Care Med. 1997
               Jul;25(7):1207-14.

               139. Petri MA, Lahita RG, Van Vollenhoven RF, et al. Effects of prasterone on corticosteroid
               requirements of women with systemic lupus erythematosus; a double- blind, randomized,
               placebo-controlled trial. Arthritis Rheum. 2002 Jul; 46(7):1820-9.
               140. Zietz B, Hrach S, Scholmerich J, Straub RH. Differential age-related changes of
               hypothalamus-pituitary-adrenal axis hormones in healthy women and men: role of interleukin-6.
               Exp Clin Endocrinol Diabetes. 2001;109(2):93-101.
               141. Straub RH, Konecna L, Hrach S, et al. Serum dehydroepiandrosterone (DHEA) and DHEA
               sulfate are negatively correlat- ed with serum interleukin-6 (IL-6), and DHEA inhibits IL-6
               secretion from mononuclear cells in man: possible link between endocrinosenescence and
               immunosenescence. J Endocrinol Metab. 1998 Jun; 83(6):2012.7.
               142. Straub RH, Lehle K, Herfarth H, et al. Dehydroepiandrosterone in relation to other adrenal
               hormones during an acute inflammatory stressful disease state compared with chronic
   21   22   23   24   25   26   27   28